Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Sumatriptan Succinate Tablets, 100 mg (a prescription migraine medication manufactured by Sun Pharmaceuticals) distributed nationwide in the USA. The recall involves one carton containing 9 blister packs due to temperature abuse during storage or handling, which violates good manufacturing practice standards. McKesson is unable to identify the specific lot number of the recalled product, but affected customers were notified by letter that included the distribution date and the dates when impacted product may have been shipped to them.
The recall notice does not specify what action affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 1 carton/9 blister packs Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.